Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 1
2005 1
2006 1
2007 4
2008 1
2009 4
2010 1
2011 1
2012 4
2013 5
2014 5
2015 9
2016 6
2017 5
2018 7
2019 9
2020 15
2021 8
2022 11
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCL.
Schmitt A, Xu W, Bucher P, Grimm M, Konantz M, Horn H, Zapukhlyak M, Berning P, Brändle M, Jarboui MA, Schönfeld C, Boldt K, Rosenwald A, Ott G, Grau M, Klener P, Vockova P, Lengerke C, Lenz G, Schulze-Osthoff K, Hailfinger S. Schmitt A, et al. Among authors: klener p. Blood. 2021 Sep 9;138(10):871-884. doi: 10.1182/blood.2020009404. Blood. 2021. PMID: 33876201 Free article.
BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis.
Schmitt A, Grimm M, Kreienkamp N, Junge H, Labisch J, Schuhknecht L, Schönfeld C, Görsch E, Tibello A, Menck K, Bleckmann A, Lengerke C, Rosenbauer F, Grau M, Zampieri M, Schulze-Osthoff K, Klener P, Dolnikova A, Lenz G, Hailfinger S. Schmitt A, et al. Among authors: klener p. Blood. 2023 Sep 28;142(13):1143-1155. doi: 10.1182/blood.2022019274. Blood. 2023. PMID: 37294920
BH3 Mimetics in Hematologic Malignancies.
Klener P, Sovilj D, Renesova N, Andera L. Klener P, et al. Int J Mol Sci. 2021 Sep 21;22(18):10157. doi: 10.3390/ijms221810157. Int J Mol Sci. 2021. PMID: 34576319 Free PMC article. Review.
Current Immunotherapy Approaches in Non-Hodgkin Lymphomas.
Pytlik R, Polgarova K, Karolova J, Klener P. Pytlik R, et al. Among authors: klener p. Vaccines (Basel). 2020 Nov 27;8(4):708. doi: 10.3390/vaccines8040708. Vaccines (Basel). 2020. PMID: 33260966 Free PMC article. Review.
Drug Resistance in Non-Hodgkin Lymphomas.
Klener P, Klanova M. Klener P, et al. Int J Mol Sci. 2020 Mar 18;21(6):2081. doi: 10.3390/ijms21062081. Int J Mol Sci. 2020. PMID: 32197371 Free PMC article. Review.
Immunotherapy Approaches in Cancer Treatment.
Klener P Jr, Otáhal P, Lateckova L, Klener P. Klener P Jr, et al. Among authors: klener p. Curr Pharm Biotechnol. 2015;16(9):771-81. doi: 10.2174/1389201016666150619114554. Curr Pharm Biotechnol. 2015. PMID: 26087990 Review.
Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma.
Patra-Kneuer M, Chang G, Xu W, Augsberger C, Grau M, Zapukhlyak M, Ilieva K, Landgraf K, Mangelberger-Eberl D, Yousefi K, Berning P, Kurz KS, Ott G, Klener P, Khandanpour C, Horna P, Schanzer J, Steidl S, Endell J, Heitmüller C, Lenz G. Patra-Kneuer M, et al. Among authors: klener p. Front Immunol. 2023 Jul 31;14:1220558. doi: 10.3389/fimmu.2023.1220558. eCollection 2023. Front Immunol. 2023. PMID: 37600821 Free PMC article.
90 results